Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 Pursuant to 21 CFR 1301.33(a), this is a notice that on June 10, 2004 Aldrich Chemical Company Inc., DBA Isotec, 3858 Benner Road, Miamisburg, Ohio 45342-4304, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed: Drug
ScheduleCathinone (1235)
IMethcathinone (1237)
IN-Ethylamphetamine (1475)
IN,N-Dimethylamphetamine (1480)
IAminorex (1585)
IGamma hydroxybutyric acid (2010)
IMethaqualone (2565)
ILysergic acid dethylamide (7315)
ITetrahydrocannabinols (7370)
IMescaline (7381)
I2,5-Dimethoxyamophetamine (7396)
I3,4-Methylenedioxyamphetamine (7400)
I3,4-Methylenedioxy-N-ethylamphetamine (7404)
I3,4-Methylenedioxy-methamphetamine (7405)
I4-Methoxyamphetamine (7411)
IPsilocybin (7437)
IPsilocyn (7438)
IN-Ethyl-1-phenylcyclohexalamine (7455)
IDihydromorphine (9145)
INormorphine (9313)
IAcetylmethadol (9601)
IAlphacetylmethadol Except Levo-Alphacetylmethadol (9603)
INormethadone (9635)
I3-Methylfentanyl (9813)
IAmphetamine (1100)
IIMethamphetamine (1105)
IIMethylphenidate (1724)
IIAmobarbital (2125)
IIPentobarbital (2270)
IISecobarbital (2315)
II1-Phenylcyclohexalamine (7460)
IIPhencyclidine (7471)
IIPhenylacetone (8501)
II1-Piperidinocyclohexane-carbonitrile (8603)
IICodeine (9050)
IIDihydrocodeine (9120)
IIOxycodone (9143)
IIHydromorphone (9150)
IIBenzoylecgonine (9180)
IIEthylmorphine (9190)
IIHydrocodone (9193)
IIIsomethadone (9226)
IIMeperidine (9230)
IIMeperidine intermediate-A (9232)
IIMeperidine intermediate-B (9233)
IIMethadone (9250)
IIMethadone intermediate (9254)
IIDextropropoxyphene, bulk, (non-dosage forms) (9273)
IILevo-alphacetylmethadol (9648)
IIOxymorphone (9652)
IIFentanyl (9801)
II
 The company plans to manufacture small quantities of the listed controlled substances to produce isotope labeled standards for drug analysis. Any other such applicant and any person who is presently registered  with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR  1301.33(a). Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC  20537, Attention: DEA Federal Register Representative (CCD) and must be filed no later than (60 days from publication). Dated: September 16, 2004. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 04-21944  Filed 9-29-04; 8:45 am] BILLING CODE 4410-09-M